Elos Medtech Gelecekteki Büyüme
Future kriter kontrolleri 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Elos Medtech.
Anahtar bilgiler
n/a
Kazanç büyüme oranı
n/a
EPS büyüme oranı
Medical Equipment kazanç büyümesi | 32.8% |
Gelir büyüme oranı | n/a |
Gelecekteki özkaynak getirisi | n/a |
Analist kapsamı | None |
Son güncelleme | n/a |
Gelecekteki son büyüme güncellemeleri
Güncelleme yok
Recent updates
Calculating The Fair Value Of Elos Medtech AB (publ) (STO:ELOS B)
Oct 11Is Now The Time To Look At Buying Elos Medtech AB (publ) (STO:ELOS B)?
May 23Here's Why I Think Elos Medtech (STO:ELOS B) Is An Interesting Stock
May 10Returns On Capital Are Showing Encouraging Signs At Elos Medtech (STO:ELOS B)
Apr 17We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt
Mar 24Should Elos Medtech AB (publ) (STO:ELOS B) Be Part Of Your Dividend Portfolio?
Mar 11The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares
Feb 28Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?
Feb 24Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment
Feb 11When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?
Jan 31How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?
Jan 18Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture
Jan 06Could The Elos Medtech AB (publ) (STO:ELOS B) Ownership Structure Tell Us Something Useful?
Dec 26Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet
Dec 13Here's Why We Don't Think Elos Medtech's (STO:ELOS B) Statutory Earnings Reflect Its Underlying Earnings Potential
Nov 30Elos Medtech AB (publ)'s (STO:ELOS B) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 17Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Elos Medtech yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.
SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.
Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
9/30/2023 | 1,018 | 55 | -52 | 95 | N/A |
6/30/2023 | 998 | 55 | -1 | 121 | N/A |
3/31/2023 | 961 | 76 | -7 | 113 | N/A |
12/31/2022 | 889 | 75 | -9 | 108 | N/A |
9/30/2022 | 843 | 94 | 7 | 123 | N/A |
6/30/2022 | 799 | 90 | -17 | 81 | N/A |
3/31/2022 | 747 | 79 | 11 | 89 | N/A |
12/31/2021 | 724 | 76 | 19 | 105 | N/A |
9/30/2021 | 694 | 67 | 14 | 96 | N/A |
6/30/2021 | 655 | 62 | 45 | 125 | N/A |
3/31/2021 | 592 | 51 | 55 | 141 | N/A |
12/31/2020 | 580 | 36 | 69 | 126 | N/A |
9/30/2020 | 584 | 33 | 74 | 116 | N/A |
6/30/2020 | 593 | 29 | 43 | 105 | N/A |
3/31/2020 | 658 | 29 | 20 | 102 | N/A |
12/31/2019 | 689 | 39 | 4 | 102 | N/A |
9/30/2019 | 700 | 35 | -4 | 107 | N/A |
6/30/2019 | 697 | 32 | -12 | 95 | N/A |
3/31/2019 | 679 | 29 | -21 | 67 | N/A |
12/31/2018 | 645 | 21 | -14 | 66 | N/A |
9/30/2018 | 625 | 24 | -12 | 66 | N/A |
6/30/2018 | 603 | 21 | 0 | 58 | N/A |
3/31/2018 | 593 | 23 | 12 | 59 | N/A |
12/31/2017 | 578 | 23 | 25 | 62 | N/A |
9/30/2017 | 562 | 18 | 40 | 68 | N/A |
6/30/2017 | 556 | 23 | N/A | 86 | N/A |
3/31/2017 | 552 | 29 | N/A | 90 | N/A |
12/31/2016 | 552 | 26 | N/A | 98 | N/A |
9/30/2016 | 555 | 27 | N/A | 95 | N/A |
6/30/2016 | 551 | 20 | N/A | 74 | N/A |
3/31/2016 | 539 | 15 | N/A | 71 | N/A |
12/31/2015 | 504 | 16 | N/A | 63 | N/A |
9/30/2015 | 474 | 17 | N/A | 120 | N/A |
6/30/2015 | 436 | 23 | N/A | 181 | N/A |
3/31/2015 | 398 | 26 | N/A | 196 | N/A |
12/31/2014 | 381 | 23 | N/A | 175 | N/A |
9/30/2014 | 371 | 25 | N/A | 120 | N/A |
6/30/2014 | 369 | 18 | N/A | 94 | N/A |
3/31/2014 | 366 | 17 | N/A | 75 | N/A |
12/31/2013 | 368 | 17 | N/A | 80 | N/A |
9/30/2013 | 396 | 20 | N/A | 82 | N/A |
6/30/2013 | 413 | 18 | N/A | 51 | N/A |
3/31/2013 | 424 | 12 | N/A | 46 | N/A |
12/31/2012 | 434 | 8 | N/A | 39 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: Insufficient data to determine if ELOS B's forecast earnings growth is above the savings rate (0.8%).
Kazançlar ve Piyasa: Insufficient data to determine if ELOS B's earnings are forecast to grow faster than the Swedish market
Yüksek Büyüme Kazançları: Insufficient data to determine if ELOS B's earnings are expected to grow significantly over the next 3 years.
Gelir ve Pazar: Insufficient data to determine if ELOS B's revenue is forecast to grow faster than the Swedish market.
Yüksek Büyüme Geliri: Insufficient data to determine if ELOS B's revenue is forecast to grow faster than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: Insufficient data to determine if ELOS B's Return on Equity is forecast to be high in 3 years time